I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 4 studies | 21% ± 2% | |
| endothelial cell | 3 studies | 20% ± 1% | |
| glutamatergic neuron | 3 studies | 39% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 4 studies | 21% ± 2% | |
| endothelial cell | 3 studies | 20% ± 1% | |
| glutamatergic neuron | 3 studies | 39% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 1705.48 | 2604 / 2642 | 100% | 38.75 | 703 / 705 |
| thymus | 99% | 823.99 | 648 / 653 | 93% | 4.93 | 562 / 605 |
| uterus | 99% | 1038.31 | 168 / 170 | 86% | 8.42 | 393 / 459 |
| prostate | 99% | 986.84 | 243 / 245 | 85% | 3.71 | 426 / 502 |
| esophagus | 99% | 1430.01 | 1437 / 1445 | 81% | 3.53 | 148 / 183 |
| lung | 100% | 1473.65 | 577 / 578 | 80% | 4.36 | 926 / 1155 |
| breast | 99% | 1222.09 | 454 / 459 | 79% | 3.80 | 879 / 1118 |
| skin | 97% | 991.83 | 1758 / 1809 | 78% | 7.92 | 369 / 472 |
| bladder | 100% | 834.48 | 21 / 21 | 74% | 3.33 | 372 / 504 |
| kidney | 84% | 465.62 | 75 / 89 | 76% | 4.60 | 683 / 901 |
| intestine | 97% | 847.22 | 941 / 966 | 62% | 2.59 | 325 / 527 |
| stomach | 87% | 961.33 | 314 / 359 | 59% | 2.76 | 170 / 286 |
| ovary | 90% | 598.64 | 162 / 180 | 53% | 2.34 | 226 / 430 |
| adrenal gland | 57% | 225.18 | 146 / 258 | 75% | 4.11 | 173 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.52 | 29 / 29 |
| adipose | 100% | 1535.21 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1594.03 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 100% | 2363.80 | 857 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 6923.30 | 924 / 929 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1279.19 | 790 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 9.87 | 44 / 45 |
| blood vessel | 97% | 996.64 | 1295 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 17% | 62.36 | 57 / 328 | 70% | 2.96 | 125 / 178 |
| eye | 0% | 0 | 0 / 0 | 61% | 2.23 | 49 / 80 |
| liver | 6% | 24.51 | 14 / 226 | 45% | 1.98 | 183 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
| GO_0019901 | Molecular function | protein kinase binding |
| Gene name | INKA2 |
| Protein name | Inka box actin regulator 2 PAK4-inhibitor INKA2 (Induced in neural crest by AP2-alpha protein-related homolog) (Inca-r) (Inka-box actin regulator 2) |
| Synonyms | C1orf183 FAM212B |
| Description | FUNCTION: Inhibitor of the serine/threonine-protein kinase PAK4. Acts by binding PAK4 in a substrate-like manner, inhibiting the protein kinase activity. . |
| Accessions | Q9NTI7 E9PR53 E9PND8 ENST00000534365.1 ENST00000357260.6 ENST00000527621.1 |
